Barbara Kienzle, BSN, RN
Augusta University’s Children’s Hospital of Georgia
Carolyn Zic, MSN, FNP-BC
Comer Children’s Hospital
New Lenox, IL
This activity has been designed to meet the educational needs of rheumatology nurses, nurse practitioners, and physician assistants. Other healthcare providers may also participate.
Learning Objective and Goal:
Upon completion of this activity, participants should be able to:
● Analyze the manner in which JIA differs from other pediatric rheumatic diseases
● Summarize the latest data surrounding the efficacy and safety of both conventional and biologic disease modifying anti-rheumatic drugs used to treat JIA
● Assess the emotional and psychological impact of JIA on adolescents and teenagers
● Incorporate the six core elements for transitioning young patients with JIA from pediatric to adult rheumatology practices.
Rheumatology Nurses Society is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (Provider No. P0500).
Participants will receive 0.5 hours of continuing nursing contact hours, with 0.5 pharmacotherapeutic hours, by completing the education and completing an online evaluation.
According to the disclosure policy of RNS, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.
Relationships are abbreviated as follows: E, Educational planning committee; G, Grant/research support recipient; A, Advisor/review panel member; C, Consultant; S, Stock shareholder; SB, Speaker bureau; PE, Promotional event talks; H, Honoraria; O, Other.
Disclosures are as follows:
Barbara Kienzle, BSN, RN, has disclosed the following relevant financial relationship specific to the subject matter of the content included in this educational activity: Mallinckrodt/A.
Carolyn Zic, MSN, FNP-BC, has disclosed the following relevant financial relationship specific to the subject matter of the content included in this educational activity: Mallinckrodt/A.
Kim Cheramie, MSN, RN-BC, Lead Nurse Planner, Rheumatology Nurses Society, has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.
Scott Kober, MBA, Managing Director, Excalibur Medical Education, has disclosed that he does not have any relevant financial relationships specific to the subject matter of the content of the activity.
Amy Karon, DVM, MPH, MA, Medical Writer, has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.
Kevin Lyons, Executive Director of the Rheumatology Nurses Society and Chief Executive Officer of Lyons Den Solutions, LLC, has disclosed that he does not have any relevant financial relationships specific to the subject matter of the content of the activity.
Off-Label Product Disclosure: This activity will not include a discussion of off-label or investigational use of products.
Method of Participation: There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CNE contact hours for your participation, please complete the activity, and program evaluation. Your certificate can be printed immediately.
Supporter: This activity is supported by an educational grant from Pfizer and Janssen Biotech, Inc., administered by
Janssen Scientific Affairs, LLC.
Expiration: This course will expire on June 15th, 2023